Común · Saberes
Pyrilutamide
Chemical compound
Pyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of androgenic alopecia (pattern hair loss) and acne. The drug is being developed by Suzhou Kintor Pharmaceuticals.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
Pyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of androgenic alopecia (pattern hair loss) and acne. The drug is being developed by Suzhou Kintor Pharmaceuticals. As of February 2025, it is in phase 3 clinical trials for androgenic alopecia and phase 2 trials for acne. The drug was also under development for the treatment of diabetic foot ulcers, but development for this indication was discontinued.
Texto: Wikipedia en inglés, CC BY-SA 4.0. · Imagen: Fluridil-god (CC BY-SA 4.0) ·
